FDA Panel: Engineered Donor Heart Valves Need PMA
Friday, October 24, 2014
Source: MedPage Today
An FDA advisory committee has recommended that "more than minimally manipulated" (MMM) allograft heart valves, which currently lack a clear classification, should be regulated as high-risk devices.
If endorsed by the agency, the recommendation could subject makers of such products to costly premarket approval studies.